SCHEDULE 13D/A

Rapport Therapeutics Inc

Common Stock, $0.001 par value · CUSIP: 75383L102

Event date: 2025-09-11

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Sofinnova Venture Partners XI, L.P. ("SVP XI")Reported CIK 0001882303

  Shares: 1,863,327.00 · Class: 4.0%

• Sofinnova Management XI, L.P. ("SM XI LP")

  Shares: 1,863,327.00 · Class: 4.0%

• Sofinnova Management XI, L.L.C. ("SM XI LLC")

  Shares: 1,863,327.00 · Class: 4.0%

• Dr. James I. Healy ("Healy")

  Shares: 1,947,579.00 · Class: 4.2%

• Dr. Maha Katabi ("Katabi")

  Shares: 1,863,327.00 · Class: 4.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.